Sarcoidosis drug study halted after just 3 patients
Disease control
Terminated
This study tested whether the drug maraviroc could reduce inflammation in the lungs of people with active sarcoidosis. Participants took the drug for 6 weeks and had two lung exams (bronchoscopy) to measure immune cells before and after treatment. Only 3 people enrolled, and the …
Phase: NA • Sponsor: Kevin F. Gibson • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC